Key result
Routine ambulatory and home blood pressure monitoring is recommended to identify true resistant hypertension, and treatment should include a renin-angiotensin system blocker and a calcium channel blocker.
Why the study?
How should resistant hypertension be diagnosed and managed in clinical practice?
How should resistant hypertension be diagnosed and managed in clinical practice?
Routine out-of-office blood pressure monitoring is essential to distinguish true from white-coat resistant hypertension and guide treatment intensification.
Supports out-of-office monitoring to confirm true resistant hypertension; leaves open prospective validation of regimens.
Hypertension resistant to lifestyle interventions and antihypertensive medications is a common problem encountered by physicians in everyday practice. It is most often defined as a blood pressure remaining ≥ 140/90 mmHg despite the regular intake of at least three drugs lowering blood pressure by different mechanisms, one of them being a diuretic. It now appears justified to include, unless contraindicated or not tolerated, a blocker of the renin-angiotensin system and a calcium channel blocker in this drug regimen, not only to gain antihypertensive efficacy, but also to prevent or regress target organ damage and delay the development of cardiorenal complications. A non-negligible fraction of treatment-resistant hypertension have normal "out of office" blood pressures. Ambulatory blood pressure monitoring and/or home blood pressure recording should therefore be routinely performed to identify patients with true resistant hypertension, i.e. patients who are more likely to benefit from treatment intensification.
No takes yet. Share an insight, caveat, or question.
Waeber et al. (2013) conducted a review in Resistant hypertension. Ambulatory blood pressure monitoring and/or home blood pressure recording was evaluated. Routine ambulatory and home blood pressure monitoring is recommended to identify true resistant hypertension, and treatment should include a renin-angiotensin system blocker and a calcium channel blocker.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: